ImmunotherapyImmunotherapy, AdoptiveAntineoplastic Combined Chemotherapy ProtocolsImmunotherapy, ActiveDesensitization, ImmunologicChemotherapy, AdjuvantCancer VaccinesAntigens, NeoplasmCombined Modality TherapyAntineoplastic AgentsNeoplasmsAdministration, SublingualSublingual ImmunotherapyTreatment OutcomeRhinitis, Allergic, SeasonalCyclophosphamideT-Lymphocytes, CytotoxicCisplatinAntibodies, MonoclonalDendritic CellsMelanomaAllergensDoxorubicinT-LymphocytesInterleukin-2Lung NeoplasmsLymphocytes, Tumor-InfiltratingCell Line, TumorCD8-Positive T-LymphocytesDisease-Free SurvivalMelanoma, ExperimentalClinical Trials as TopicSurvival AnalysisBreast NeoplasmsCytotoxicity, ImmunologicImmunization, PassiveNeoadjuvant TherapyNeoplasm StagingMice, Inbred C57BLHLA-A2 AntigenPrognosisLymphocyte ActivationBee VenomsSurvival RateTumor EscapeMice, Inbred BALB CDrug Administration SchedulePollenImmunoglobulin EEtoposideBCG VaccineNeoplasm MetastasisAntigens, PlantCytokine-Induced Killer CellsAntibodies, NeoplasmAlzheimer VaccinesAdjuvants, ImmunologicHypersensitivityInterferon-gammaHLA-A24 AntigenEpitopes, T-LymphocyteNeoplasms, ExperimentalInsect Bites and StingsRhinitis, Allergic, PerennialNeoplasm Recurrence, LocalFlow CytometryMethotrexateHLA-A AntigensTime FactorsNeoplasm TransplantationTumor Cells, CulturedMelanoma-Specific AntigensCD4-Positive T-LymphocytesKidney NeoplasmsBrain NeoplasmsOvarian NeoplasmsKiller Cells, NaturalNeoplasm ProteinsAntineoplastic Agents, AlkylatingDrug Resistance, NeoplasmPicibanilCarboplatinVinblastinegp100 Melanoma AntigenAdenocarcinomaPaclitaxelT-Lymphocytes, RegulatoryCarcinoma, Renal CellCytokinesKiller Cells, Lymphokine-ActivatedInduction ChemotherapyAntigen PresentationMice, TransgenicInjections, SubcutaneousImmune ToleranceAntimetabolites, AntineoplasticWasp VenomsTransplantation, AutologousRecombinant ProteinsImmunologic Factors